חובות לטווח קצר של החברה: Impact BioMedical Inc (IBO)

Impact BioMedical Inc (IBO) relies on US laboratories, outsourcing production to third-party contractors to maintain flexibility. The asset's market valuation trend on GURU.Markets, where the indicator stands at 0.00, confirms an expansion phase for proprietary medical solutions with a focus on partnerships by 2026. Meanwhile, revenue volatility persists due to the focus on patent creation and irregular licensing payments.

When assessing the long-term risks of Impact BioMedical Inc (IBO), investors must analyze current liabilities due within one year, which measure the volume of floating-rate loans sensitive to regulatory decisions. This trend determines the cost of servicing liabilities, which is critical for maintaining the stability of the holding structure that diversifies revenues from patent licensing in the fields of antivirals and sugar substitutes.